O. Ming

Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China

Chengzhi Zhou, Shuanying Yang, L. Qun, 2021, Frontiers in Molecular Biosciences.

Efficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.

Rongchang Chen, N. Zhong, Shiyue Li, 2015, International journal of clinical and experimental medicine.

Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases.

W. Guan, Rongchang Chen, N. Zhong, 2019, Clinical lung cancer.

A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung

N. Zhong, W. Feng, Shiyue Li, 2019, Modern Pathology.

Detection of epidermal growth factor receptor mutations in plasma by mutant‐enriched PCR assay for prediction of the response to gefitinib in patients with non‐small‐cell lung cancer

N. Zhong, Ming Liu, Jiexia Zhang, 2009, International journal of cancer.

The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research

Ming Liu, Chengzhi Zhou, C. Su, 2022, Frontiers in Oncology.

MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus-specific.

J. Burnside, Ming Ouyang, B. Meyers, 2009, Virology.

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer

Shiyue Li, Ming Liu, Chengzhi Zhou, 2021, Frontiers in Oncology.

Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma.

Shi-yue Li, Jiexia Zhang, Chengzhi Zhou, 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.